- Home
- VIVK vs PMN Comparison
VIVK vs PMN Comparison
Compare VIVK & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVK
- PMN
- Stock Information
- Founded
- VIVK 2006
- PMN 2004
- Country
- VIVK United States
- PMN Canada
- Employees
- VIVK N/A
- PMN N/A
- Industry
- VIVK Oilfield Services/Equipment
- PMN Pharmaceuticals and Biotechnology
- Sector
- VIVK Energy
- PMN Health Care
- Exchange
- VIVK Nasdaq
- PMN Nasdaq
- Market Cap
- VIVK 25.6M
- PMN 23.5M
- IPO Year
- VIVK N/A
- PMN N/A
- Fundamental
- Price
- VIVK $0.17
- PMN $0.41
- Analyst Decision
- VIVK
- PMN Strong Buy
- Analyst Count
- VIVK 0
- PMN 3
- Target Price
- VIVK N/A
- PMN $4.33
- AVG Volume (30 Days)
- VIVK 85.3M
- PMN 528.6K
- Earning Date
- VIVK 11-20-2025
- PMN 11-14-2025
- Dividend Yield
- VIVK N/A
- PMN N/A
- EPS Growth
- VIVK N/A
- PMN N/A
- EPS
- VIVK N/A
- PMN N/A
- Revenue
- VIVK $124,048,464.00
- PMN N/A
- Revenue This Year
- VIVK N/A
- PMN N/A
- Revenue Next Year
- VIVK N/A
- PMN N/A
- P/E Ratio
- VIVK N/A
- PMN N/A
- Revenue Growth
- VIVK 98.83
- PMN N/A
- 52 Week Low
- VIVK $0.17
- PMN $0.38
- 52 Week High
- VIVK $1.68
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- VIVK 32.64
- PMN 39.86
- Support Level
- VIVK $0.20
- PMN $0.40
- Resistance Level
- VIVK $0.36
- PMN $0.48
- Average True Range (ATR)
- VIVK 0.06
- PMN 0.03
- MACD
- VIVK 0.01
- PMN -0.00
- Stochastic Oscillator
- VIVK 3.40
- PMN 14.40
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.